Inhaling xenon ameliorates l -dopa-induced dyskinesia in experimental parkinsonism

Jérôme Baufreton (1, 1, 1) , Tomislav Milekovic (2) , Qin Li (3) , Steve Mcguire (4) , Eduardo Martin Moraud (5) , Gregory Porras (1) , Shiqi Sun , Wai Kin D. Ko (4) , Marine Chazalon (1) , Stephanie Morin (1) , Elisabeth Normand (6) , Géraldine Farjot , Aude Milet (7) , Jan Pype , Elsa Pioli (8) , Grégoire Courtine (2) , Baptiste Bessière , Erwan Bezard (1)

1 IMN - Institut des Maladies Neurodégénératives [Bordeaux]
2 Center for Neuroprosthetics and Brain Mind Institute
3 Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China
4 Motac Neuroscience, Manchester, United Kingdom.
5 Bertarelli Foundation Chair in Translational Neuroengineering
6 IINS - Interdisciplinary Institute for Neuroscience [Bordeaux]
7 Génétique moléculaire, neurophysiologie et comportement
8 Motac Neuroscience

Domaines: Neurobiologie

Jérôme Baufreton, Tomislav Milekovic, Qin Li, Steve Mcguire, Eduardo Martin Moraud, et al.. Inhaling xenon ameliorates l -dopa-induced dyskinesia in experimental parkinsonism. Movement Disorders, 2018, 33 (10), pp.1632-1642. ⟨10.1002/mds.27404⟩. ⟨hal-02275286⟩